388
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Time to Recovery from Covid-19 and Its Predictors Among Patients Admitted to Treatment Centers of Southern Nations Nationalities and Peoples Region (SNNPR), ETHIOPIA: Multi-Center Retrospective Cohort Study

ORCID Icon, , , ORCID Icon, , ORCID Icon, ORCID Icon & show all
Pages 3047-3062 | Published online: 16 Jun 2022

References

  • Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382 (18):1708–1720. doi:10.1056/NEJMoa2002032
  • Ma X, Wang D, Xu W, et al. A novel coronavirus from patients with pneumonia in China, 2019. 2020;727–733.
  • Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109 (February):102433. doi:10.1016/j.jaut.2020.102433
  • World Health Organaization. Transmission of SARS-CoV-2_ implications for infection prevention precautions; 2020.
  • World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization; 2020.
  • Prem K, Liu Y, Russell TW, Kucharski AJ, Eggo RM, Davies N. Articles the effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health. 2020;5:261–270.
  • Level R, Level G, High V. Novel Coronavirus (2019-nCoV). 2020.
  • World Health Organaization. Coronavirus disease (COVID-19); 2020.
  • Bezzio C, Variola A, Allocca M, et al. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020;69:1213–1217. doi:10.1136/gutjnl-2020-321411
  • Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol. 2020;31 (6):1157–1165. doi:10.1681/ASN.2020030276
  • Bellosta R, Luzzani L, Natalini G, Pegorer A. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020;72 (January):1864–1872. doi:10.1016/j.jvs.2020.04.483
  • The World Economic Forum. COVID action platform _ world economic forum.
  • Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network-United States, march-june 2020 [internet]; 2020: 69. Available from: https://www.cdc.gov/mmwr. Accessed June 10, 2022.
  • Meng Y, Wu P, Lu W, et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China_ A retrospective study of 168 severe patients _ enhanced reader. PLoS Pathog. 2020;16 (4):e1008520. doi:10.1371/journal.ppat.1008520
  • Zhou B, She J, Wang Y, Ma X Clinical infectious diseases ® 2020;71 (16):2240-2Duration of viral shedding of discharged patients with severe COVID-19. Available from: www.gov.cn/zhengce/zhengceku/2020-01/28/5472673/files/0f96c10cc09d4d36a6. Accessed June 10, 2022.
  • Wootton DG, Dickinson L, Pertinez H, et al. A longitudinal modelling study estimates pneumonia recover to baseline by 10 days. Eur Respir J. 2017;49. doi:10.1183/13993003.02170-2016
  • Tiewsoh K, Lodha R, Pandey RM, Broor S, Kalaivani M, Kabra SK. Factors determining the outcome of children hospitalized with severe pneumonia. BMC Pediatr. 2009;9:15. doi:10.1186/1471-2431-9-15
  • Ababa A. Federal democratic republic of Ethiopia central statistical agency population projection of Ethiopia for all regions at wereda level from 2014 – 2017; 2017.
  • ADDIS Standard. NEWS_ SNNPRS council approves legal framework which makes hawassa city accountable to future sidama regional state - Addis standard.
  • Ciceri F, Castagna A, Rovere-querini P, et al. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy. Clin Immunol. 2020;217 (May):108509. doi:10.1016/j.clim.2020.108509
  • Pintilie M. Power and Sample size for time to event analysis type I and II errors; 2013:1–28.
  • Oda Y, Shimada M, Shiraishi S, Kurai O. Treatment and outcome of COVID-19 patients in a specialized hospital during the third wave: advance of age and increased mortality compared with the first/second waves. JA Clin Reports. 2021;7. doi:10.1186/s40981-021-00489-x
  • Chen X, Zhu B, Hong W, Zeng J, He X, Chen J. Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19. Int J Infect Dis. 2020;98:252–260. doi:10.1016/j.ijid.2020.06.091
  • Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323 (15):1488–1494. doi:10.1001/jama.2020.3204
  • Kaijin X, Chen Y, Yuan J, et al. Factors associated with prolonged viral RNA shedding in patients with COVID-19.
  • Id TWL, Hassen IS, Maru EH, et al. Characteristics and outcome profile of hospitalized African patients with COVID-19: the Ethiopian context. PLoS One. 2021;71:1–15. doi:10.1371/journal.pone.0259454
  • Id TT, Id BW, Seyoum D, Id G, Merdassa E. Time to recovery from COVID-19 and its predictors among patients admitted to treatment center of Wollega University Referral Hospital (WURH), Western Ethiopia: survival analysis of retrospective cohort study. PLoS One. 2021;8:1–12. doi:10.1371/journal.pone.0252389
  • Shi D, Wu W, Wang Q, et al. Clinical characteristics and factors associated with long-term viral excretion in patients with severe acute respiratory syndrome coronavirus 2 infection: a single-center 28-day study. J Infect Dis. 2020;222 (6):910–918. doi:10.1093/infdis/jiaa388
  • Abdella S, Id A, Tessema M, et al. Time to recovery and its predictors among adults hospitalized with COVID-19: a prospective cohort study in Ethiopia. PloS one. 2020;15:1–11.
  • Mamo AG, Merga BT, Birhanu A, Alemu A, Belay Negash YD, Dessie Y. Predictors of mortality among hospitalized COVID-19 patients at a tertiary care hospital in in Ethiopia. Infect Drug Resist. 2021;14:5363–5373. doi:10.2147/IDR.S337699
  • Lori Daniels B, Amy Sitapati M, Zhang J, et al. Relation of Statin use prior to admission to severity and recovery among COVID-19 inpatients – pubMed. Am J Cardiol. 2020;136:149–155. doi:10.1016/j.amjcard.2020.09.012
  • Williams V, Jayashree M, Nallasamy K, et al. 0.9% saline versus plasma-lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial.. Critical Care. 2020;24 (1):1–11. doi:10.1186/s13054-019-2683-3
  • Kaso AW, Hareru HE, Kaso T, Agero G. Factors associated with poor treatment outcome among hospitalized COVID-19 patients in South Central, Ethiopia. BioMed Res Int. 2022;2022. doi:10.1155/2022/4551132
  • Laila D, Id R, Isnaini S. Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta. PLoS One. 2021;16 (4):e0250147. doi:10.1371/journal.pone.0250147
  • Liu J, Sumeng L, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients - PubMed. EBioMed. 2020;55:102763. doi:10.1016/j.ebiom.2020.102763
  • Li Y, Yang T, Wang S, et al. The value of lymphocyte count in determining the severity of COVID-19 and estimating the time for nucleic acid test results to turn negative - PubMed. Bosn J Basic Med Sci. 2021;21 (2):235. doi:10.17305/bjbms.2020.4868
  • Shi D, Wu W, Wang Q, et al. Clinical characteristics and factors associated with long-term viral excretion in patients with severe acute respiratory syndrome coronavirus 2 infection: a single-center 28-day study. J Infect Dis. 2020;222 (6):910–918.